Ramsey Cheung

Clinical Focus

• Chronic Hepatitis B
• Chronic Hepatitis C
• Gastroenterology
• Hepatology (Liver)

Administrative Appointments

• Director, Fellowship in GI & Hepatology, Stanford (2004 - present)
• Chief of Hepatology, VAPAHCS (1999 - present)
• Associate Director, Fellowship in GI & Hepatology, Stanford (2002 - 2004)
• Director of Endoscopy, VAPAHCS (1997 - 1998)
• Chief of Gastroenterology, VA-Livermore (1993 - 1995)

Honors and Awards

• Teaching Award, Department of Medicine (2002, 2004, 2006, 2007)

Professional Education

• Board Certification: Gastroenterology, American Board of Internal Medicine (1991)
• Fellowship: SUMC - Graduate Medical Education, CA (1991)
• Board Certification: Internal Medicine, American Board of Internal Medicine (1986)
• Residency: UCI College of Medicine, CA (1985)
• Internship: UCI College of Medicine, CA (1983)

Postdoctoral Advisees

Walter Park

Research Interests

Dr. Cheung's past research utilized the duck animal model to study the mechanism of viral neutralization of hepatitis B virus at the molecular level. In collaboration with basic scientists, he is interested in using molecular biology approaches to study clinical samples from chronic hepatitis C patients and investigate the host-virus interaction. The ultimate goal is to understand the pathogenesis of HCV and mechanism of anti-viral therapy. Dr. Cheung is also investigating the healthcare model of hepatitis C care among infected veterans, interaction between hepatitic C infection and alcoholic cirrhosis, and impact of comorbid conditions on the health related quality of life. He is investigating methods to improve care of veterans with chronic hepatitis C, including use of the novel experimental anti-viral therapies as part of clinical trails. Dr. Cheung also used VA and other database to study various healthcare issues in patients with chronic hepatitis C.

Publications

• The impact of chronic hepatitis C and co-morbid illnesses on health-related quality of life. Kwan JW, Cronkite RC, Yiu A, Goldstein MK, Kazis L, Cheung RC "Qual Life Res" 2008 ; 5 (17) : 715-24
• A 7 gene signature identifies the risk of developing cirrhosis in patients with chronic hepatitis C. Huang H, Shiffman ML, Friedman S, Venkatesh R, Bzowej N, Abar OT, Rowland CM, Catanese JJ, Leong DU, Sninsky JJ, Layden TJ, Wright TL, White T, Cheung RC "Hepatology" 2007 ; 2 (46) : 297-306
• Incidence of statin hepatotoxicity in patients with hepatitis C. Khorashadi S, Hasson NK, Cheung RC "Clin Gastroenterol Hepatol" 2006 ; 7 (4) : 902-7; quiz 806
• Epidemiology of hepatitis C virus infection in American veterans. Cheung RC, "Am J Gastroenterol" 2000 ; 3 (95) : 740-7
• Treatment eligibility and outcomes in elderly patients with chronic hepatitis C: results from the VA HCV-001 Study. Tsui JI, Currie S, Shen H, Bini EJ, Brau N, Wright TL "Dig Dis Sci" 2008 ; 3 (53) : 809-14